1. Sendagire H, Easterbrook PJ, Nankya I, Arts E, Thomas D, Reynolds SJ (2009) The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART. AIDS Rev 11:59–70
2. Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Schuurman R, PharmAccess African Studies to Evaluate Resistance Programme (2008) The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. Antivir Ther 13:625–639
3. World Health Organization (WHO) recommendations (2010) Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach 2010 revision. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf . Accessed 3 Jan 2011
4. Charpentier C, Talla F, Nguepi E, Si-Mohamed A, Bélec L (2010) Virological failure and HIV-1 drug resistance profiles among patients followed-up in private sector, Douala, Cameroon. AIDS Res Hum Retroviruses 2011(27):221–230
5. Gody JC, Charpentier C, Mbitikon O, Si-Mohamed A, LeGoff J, Grésenguet G, Bélec L (2008) High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations. J Acquir Immune Defic Syndr 49:566–569